Legend Biotech (LEGN) Financial Statements

Price: $33.46
Market Cap: $3.07B
Avg Volume: 1.31M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.208
52W Range: $29.265-60.87
Website: Legend Biotech

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Legend Biotech.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.00-$200.00M-$200.00M2018201820192019202020202021202120222022202320232024202420252025
Operating Expenses
Operating Income
Operating Expenses & Income$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00-$300.00M-$300.00M-$600.00M-$600.00M2018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017
Revenue $627.24M $285.14M $117.00M $89.79M $75.68M $57.26M $49.13M $23.59M
Cost of Revenue $234.58M $144.21M $65.36M $313.35M $232.16M $- $- $-96.00K
Gross Profit $392.66M $140.93M $51.64M $-223.55M $-156.48M $57.26M $49.13M $23.69M
Gross Profit Ratio 62.60% 49.42% 44.14% -248.97% -206.78% 100.00% 100.00% 100.41%
Research and Development Expenses $413.54M $382.22M $335.65M $313.35M $232.16M $161.94M $60.64M $8.20M
General and Administrative Expenses $136.78M $106.77M $80.63M $46.94M $23.15M $6.75M $2.77M $1.62M
Selling and Marketing Expenses $147.48M $94.16M $93.42M $102.54M $49.57M $25.62M $1.16M $-217.00K
Selling General and Administrative Expenses $284.26M $200.93M $174.05M $149.48M $72.72M $32.37M $3.93M $1.40M
Other Expenses $-1.91M $- $2.23M $-6.07M $-74.21M $-1.68M $-2.00K $-
Operating Expenses $695.90M $140.93M $509.70M $462.83M $304.88M $192.63M $64.20M $9.60M
Cost and Expenses $930.48M $727.36M $575.06M $462.83M $304.88M $192.63M $64.20M $9.81M
Interest Income $61.20M $54.49M $8.18M $971.00K $2.93M $4.58M $6.21M $1.00K
Interest Expense $21.61M $21.79M $10.80M $900.00K $4.21M $223.00K $82.00K $-
Depreciation and Amortization $23.36M $20.45M $18.39M $13.92M $9.93M $5.26M $1.68M $217.00K
EBITDA $-113.16M $-477.87M $-416.54M $-392.38M $-294.14M $-124.89M $149.00K $14.06M
EBITDA Ratio -18.04% -167.59% -356.00% -436.99% -388.69% -218.09% 0.30% 59.57%
Operating Income $-303.24M $-439.49M $-455.83M $-393.02M $-313.35M $-130.87M $-1.53M $13.78M
Operating Income Ratio -48.35% -154.13% -389.58% -437.71% -414.06% -228.54% -3.12% 58.41%
Total Other Income Expenses Net $145.11M $-80.63M $10.10M $-14.17M $-78.41M $5.00M $13.46M $-40.00K
Income Before Tax $-158.13M $-520.12M $-445.72M $-386.21M $-307.62M $-130.37M $-1.62M $13.84M
Income Before Tax Ratio -25.21% -182.41% -380.94% -430.11% -406.50% -227.66% -3.29% 58.65%
Income Tax Expense $18.89M $-1.86M $625.00K $1.00K $-4.14M $2.60M $1.17M $4.47M
Net Income $-177.03M $-518.25M $-446.35M $-386.21M $-303.48M $-132.97M $-2.78M $9.37M
Net Income Ratio -28.22% -181.75% -381.48% -430.12% -401.02% -232.21% -5.67% 39.69%
EPS $-0.97 $-2.94 $-2.81 $-2.74 $-2.57 $-1.01 $-0.03 $0.07
EPS Diluted $-0.97 $-2.94 $-2.81 $-2.74 $-2.57 $-1.01 $-0.03 $0.07
Weighted Average Shares Outstanding 182.85M 176.08M 159.04M 140.85M 118.15M 132.01M 100.00M 132.01M
Weighted Average Shares Outstanding Diluted 182.85M 176.08M 159.04M 140.85M 118.15M 132.01M 100.21M 132.01M
SEC Filing Source Source Source Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$2.00B$2.00B$1.50B$1.50B$1.00B$1.00B$500.00M$500.00M$0.00$0.002018201820192019202020202021202120222022202320232024202420252025
Equity$1.50B$1.50B$1.20B$1.20B$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00-$300.00M-$300.00M2018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017
Cash and Cash Equivalents $286.75M $1.28B $786.03M $688.94M $455.69M $83.36M $210.17M $2.12M
Short Term Investments $835.93M $31.00M $239.62M $193.46M $50.00M $75.56M $6.01M $-
Cash and Short Term Investments $1.12B $1.31B $1.03B $882.39M $505.69M $158.92M $216.18M $2.12M
Net Receivables $124.89M $157.06M $45.52M $50.50M $75.62M $35.76M $108.57M $227.98M
Inventory $23.90M $19.43M $10.35M $1.75M $1.80M $1.16M $1.14M $11.00K
Other Current Assets $12.44M $12.59M $62.84M $15.20M $10.84M $11.27M $1.07M $791.00K
Total Current Assets $1.28B $1.50B $1.10B $948.75M $592.86M $207.10M $326.96M $230.90M
Property Plant Equipment Net $201.59M $189.68M $161.67M $155.08M $121.32M $75.46M $33.12M $2.93M
Goodwill $- $- $- $- $-4.85M $- $- $-
Intangible Assets $174.22M $4.06M $3.41M $4.68M $7.70M $5.15M $49.00K $2.00K
Goodwill and Intangible Assets $174.22M $4.06M $3.41M $4.68M $2.85M $5.15M $49.00K $2.00K
Long Term Investments $4.36M $4.36M $395.00K $4.71M $- $- $-1.24M $-4.86M
Tax Assets $- $285.00K $-395.00K $- $- $- $68.92M $4.86M
Other Non-Current Assets $6.06M $152.42M $66.76M $5.15M $3.97M $- $1.24M $4.86M
Total Non-Current Assets $386.24M $350.81M $231.84M $169.62M $128.15M $80.61M $102.09M $7.79M
Other Assets $- $- $- $- $- $- $- $1
Total Assets $1.67B $1.85B $1.33B $1.12B $721.01M $287.71M $429.05M $238.69M
Account Payables $37.19M $20.16M $32.89M $7.04M $4.91M $9.59M $7.32M $4.33M
Short Term Debt $4.79M $3.17M $7.13M $911.00K $1.46M $1.03M $373.00K $64.00K
Tax Payables $24.04M $7.20M $9.77M $515.00K $8.79M $- $74.54M $9.33M
Deferred Revenue $47.41M $53.01M $451.00K $60.95M $55.30M $46.29M $40.32M $30.21M
Other Current Liabilities $164.21M $132.87M $248.00M $220.74M $100.11M $70.85M $36.63M $38.39M
Total Current Liabilities $277.64M $216.42M $297.79M $280.27M $161.17M $127.76M $159.19M $52.12M
Long Term Debt $345.81M $325.50M $280.97M $122.06M $1.91M $5.06M $3.94M $205.00K
Deferred Revenue Non-Current $6.15M $55.27M $7.66M $242.58M $275.07M $277.76M $257.27M $174.20M
Deferred Tax Liabilities Non-Current $- $- $- $1.87M $2.05M $-41.99M $-213.20M $-174.20M
Other Non-Current Liabilities $- $56.00K $7.89M $2.26M $2.60M $- $- $-
Total Non-Current Liabilities $351.96M $380.82M $288.86M $366.89M $279.58M $282.82M $261.21M $174.40M
Other Liabilities $- $- $- $- $- $- $- $-
Total Liabilities $629.61M $597.24M $586.65M $647.16M $440.75M $410.58M $420.40M $226.53M
Preferred Stock $- $- $222.14M $- $- $123.35M $- $-
Common Stock $37.00K $36.00K $33.00K $31.00K $27.00K $20.00K $20.00K $20.00K
Retained Earnings $-1.66B $-1.48B $-966.46M $-816.97M $-430.76M $-127.28M $5.69M $8.47M
Accumulated Other Comprehensive Income Loss $-68.16M $98.92M $744.28M $471.18M $280.23M $-122.89M $8.63M $-236.00K
Other Total Stockholders Equity $2.77B $2.64B $1.66B $1.26B $708.31M $5.88M $3.91M $3.91M
Total Stockholders Equity $1.04B $1.25B $744.31M $471.21M $280.25M $-122.87M $8.65M $12.17M
Total Equity $1.04B $1.25B $744.31M $471.21M $280.25M $-122.87M $8.65M $12.17M
Total Liabilities and Stockholders Equity $1.67B $1.85B $1.33B $1.12B $721.01M $287.71M $429.05M $238.69M
Minority Interest $- $- $- $- $- $- $- $-
Total Liabilities and Total Equity $1.67B $1.85B $1.33B $1.12B $721.01M $287.71M $429.05M $238.69M
Total Investments $840.30M $35.37M $239.62M $198.16M $50.00M $75.56M $6.01M $-4.86M
Total Debt $350.60M $328.67M $284.53M $122.97M $3.37M $6.08M $4.32M $269.00K
Net Debt $63.85M $-949.04M $-501.50M $-565.97M $-452.32M $-77.28M $-205.85M $-1.85M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$600.00M$600.00M$300.00M$300.00M$0.00$0.00-$300.00M-$300.00M-$600.00M-$600.00M-$900.00M-$900.00M2018201820192019202020202021202120222022202320232024202420252025
Financing Cash Flow$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.002018201820192019202020202021202120222022202320232024202420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018 December 31, 2017
Net Income $-158.13M $-518.25M $-445.72M $-386.21M $-307.62M $-130.37M $-1.62M $9.37M
Depreciation and Amortization $23.36M $20.45M $18.39M $13.92M $9.93M $5.26M $1.68M $217.00K
Deferred Income Tax $- $- $- $-174.94M $9.22M $-7.35M $-5.66M $-
Stock Based Compensation $68.94M $47.68M $34.34M $20.16M $4.76M $1.27M $704.00K $-
Change in Working Capital $20.04M $-71.34M $186.32M $140.87M $-23.92M $52.48M $318.71M $-16.50M
Accounts Receivables $93.75M $-98.98M $50.32M $24.59M $-45.00M $-3.77M $207.61M $-228.06M
Inventory $-17.21M $-12.71M $-8.61M $51.00K $-643.00K $-22.00K $-1.12M $-6.00K
Accounts Payables $14.06M $-12.70M $25.85M $1.80M $-4.35M $2.01M $3.24M $4.17M
Other Working Capital $-70.57M $53.04M $118.75M $114.42M $26.07M $54.27M $108.99M $207.40M
Other Non Cash Items $-98.24M $128.19M $6.65M $187.74M $84.62M $-4.36M $-6.13M $228.87M
Net Cash Provided by Operating Activities $-144.03M $-393.28M $-200.03M $-198.47M $-223.00M $-83.06M $307.68M $-2.38M
Investments in Property Plant and Equipment $-14.11M $-20.08M $-22.27M $-47.11M $-49.78M $-39.17M $-21.02M $-887.00K
Acquisitions Net $- $- $- $3.21M $4.03M $-460.00K $20.00K $60.00K
Purchases of Investments $-2.71B $-4.86B $-654.97M $-377.96M $-72.68M $-390.40M $-6.00M $-
Sales Maturities of Investments $1.93B $5.07B $613.61M $230.08M $98.29M $320.85M $- $-
Other Investing Activities $-54.34M $-91.70M $-14.71M $-3.20M $-4.03M $50.52M $-75.23M $55.00K
Net Cash Used for Investing Activities $-850.54M $92.79M $-78.34M $-194.98M $-24.17M $-58.65M $-102.26M $-827.00K
Debt Repayment $-4.02M $-3.75M $-2.60M $-1.42M $-2.60M $-5.06M $-219.00K $-32.00K
Common Stock Issued $- $583.69M $377.64M $623.44M $462.08M $- $- $1.43M
Common Stock Repurchased $- $- $- $- $- $- $- $-
Dividends Paid $- $- $- $- $- $- $- $-
Other Financing Activities $9.72M $211.56M $2.93M $4.64M $159.40M $19.72M $2.72M $3.35M
Net Cash Used Provided by Financing Activities $5.70M $791.49M $377.98M $626.66M $618.88M $14.67M $2.50M $3.32M
Effect of Forex Changes on Cash $-2.08M $682.00K $-2.51M $34.00K $620.00K $249.00K $124.00K $9.00K
Net Change in Cash $-990.96M $491.68M $97.09M $233.25M $372.32M $-126.80M $208.05M $128.00K
Cash at End of Period $286.75M $1.28B $786.03M $688.94M $455.69M $83.36M $210.17M $2.12M
Cash at Beginning of Period $1.28B $786.03M $688.94M $455.69M $83.36M $210.17M $2.12M $1.99M
Operating Cash Flow $-144.03M $-393.28M $-200.03M $-198.47M $-223.00M $-83.06M $307.68M $-2.38M
Capital Expenditure $-14.11M $-22.72M $-22.27M $-47.11M $-49.78M $-39.17M $-21.02M $-887.00K
Free Cash Flow $-158.14M $-416.00M $-222.30M $-245.58M $-272.78M $-122.23M $286.66M $-3.26M